S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Phathom PharmaceuticalsApplied TherapeuticsKaryopharm TherapeuticsCytokineticsGossamer Bio
SymbolNASDAQ:PHATNASDAQ:APLTNASDAQ:KPTINASDAQ:CYTKNASDAQ:GOSS
Price Information
Current Price$33.16$33.49$18.76$12.01$10.17
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$34.67$54.00$30.71$22.17$27.80
% Upside from Price Target4.54% upside61.24% upside63.72% upside84.57% upside173.35% upside
Trade Information
Market Cap$871.83 million$699.94 million$1.17 billion$729.57 million$696.57 million
BetaN/AN/A1.691.180.67
Average Volume92,011192,2181,702,803919,264499,606
Sales & Book Value
Annual RevenueN/AN/A$40.89 million$26.87 millionN/A
Price / SalesN/AN/A30.0726.58N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$9.29 per shareN/A$0.79 per share($0.19) per share$5.34 per share
Price / BookN/AN/A23.75-63.21N/A
Profitability
Net Income$-255,130,000.00N/A$-199,590,000.00$-121,690,000.00$-180,310,000.00
EPS($13.98)($3.55)($3.22)($2.11)($3.29)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-488.08%-452.92%N/A
Return on Equity (ROE)N/AN/A-254.74%-10,351.99%-43.11%
Return on Assets (ROA)N/AN/A-71.41%-55.69%-37.57%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.10%N/A2.47%N/A0.11%
Current Ratio68.20%N/A6.01%8.98%11.09%
Quick Ratio68.20%N/A6.00%8.98%11.09%
Ownership Information
Institutional Ownership Percentage88.95%20.92%89.95%92.57%61.21%
Insider Ownership PercentageN/AN/A11.63%5.70%23.30%
Miscellaneous
Employees124332130118
Shares Outstanding28.97 million21.97 million65.55 million59.46 million66.34 million
Next Earnings Date6/18/2020 (Estimated)6/19/2020 (Estimated)5/14/2020 (Estimated)5/14/2020 (Estimated)5/12/2020 (Estimated)
OptionableNot OptionableNot OptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel